Rosmarinic acid/Se4+ self-assembled nanoparticles for combinational therapy of triple-negative breast cancer
Year: 2025
Type: article
Language: en
Topic: Nanoplatforms for cancer theranostics
Authors and affiliations:
raw_author_name: Chong Qiu
raw_affiliation_strings: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China; Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang, 330115, China
raw_author_name: Xinyu Zhou
raw_affiliation_strings: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China; Public Health of Guangxi Medical University, Nanning, 530021, China
raw_author_name: Qingchao Tu
raw_affiliation_strings: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China
raw_author_name: LinYing Zhong
raw_affiliation_strings: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China
raw_author_name: Yuanfeng Fu
raw_affiliation_strings: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China
raw_author_name: Yinan Liu
raw_affiliation_strings: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China
raw_author_name: Yuqing Meng
raw_affiliation_strings: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China
raw_author_name: Qiaoli Shi
raw_affiliation_strings: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China
raw_author_name: Junzhe Zhang
raw_affiliation_strings: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China
raw_author_name: Shuntao Liang
raw_affiliation_strings: Biomedical Innovation Center, BeiJing Shijitan Hospitals, Capital Medical University, Beijing, 100038, China. Electronic address: lstswjs@163.com
raw_author_name: Fei Xia
raw_affiliation_strings: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China; Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang, 330115, China. Electronic address: fxia@icmm.ac.cn
raw_author_name: Jigang Wang
raw_affiliation_strings: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China; Public Health of Guangxi Medical University, Nanning, 530021, China; Shandong Academy of Chinese Medicine, Jinan 250014, China. Electronic address: jgwang@icmm.ac.cn